126 related articles for article (PubMed ID: 28042103)
41. Permeation of quinine across sublingual mucosa, in vitro.
Ong CM; Heard CM
Int J Pharm; 2009 Jan; 366(1-2):58-64. PubMed ID: 18835345
[TBL] [Abstract][Full Text] [Related]
42. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs.
Potrč T; Baumgartner S; Roškar R; Planinšek O; Lavrič Z; Kristl J; Kocbek P
Eur J Pharm Sci; 2015 Jul; 75():101-13. PubMed ID: 25910438
[TBL] [Abstract][Full Text] [Related]
43. [Taste-masking possibilities in solid dosage forms].
Szakonyi G; Zelkó R
Acta Pharm Hung; 2012; 82(2):81-90. PubMed ID: 22870781
[TBL] [Abstract][Full Text] [Related]
44. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
45. Microwave generated solid dispersions containing Ibuprofen.
Moneghini M; Bellich B; Baxa P; Princivalle F
Int J Pharm; 2008 Sep; 361(1-2):125-30. PubMed ID: 18573321
[TBL] [Abstract][Full Text] [Related]
46. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
Parojcić J; Corrigan OI
Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
[TBL] [Abstract][Full Text] [Related]
47. Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug Applications.
Suarez-Sharp S; Delvadia PR; Dorantes A; Duan J; Externbrink A; Gao Z; Ghosh T; Miksinski SP; Seo P
AAPS J; 2016 May; 18(3):578-88. PubMed ID: 26928450
[TBL] [Abstract][Full Text] [Related]
48. Development of oral taste masked diclofenac formulations using a taste sensing system.
Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
Int J Pharm; 2012 Nov; 438(1-2):81-90. PubMed ID: 22982164
[TBL] [Abstract][Full Text] [Related]
49. Taste-masking assessment of solid oral dosage forms--a critical review.
Pein M; Preis M; Eckert C; Kiene FE
Int J Pharm; 2014 Apr; 465(1-2):239-54. PubMed ID: 24509066
[TBL] [Abstract][Full Text] [Related]
50. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
51. Biorelevant in vitro assessment of dissolution and compatibility properties of a novel paediatric hydrocortisone drug product following exposure of the drug product to child-appropriate administration fluids.
Wollmer E; Neal G; Whitaker MJ; Margetson D; Klein S
Eur J Pharm Biopharm; 2018 Dec; 133():277-284. PubMed ID: 30385421
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
53. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
Jan SU; Khan GM; Hussain I
Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
[TBL] [Abstract][Full Text] [Related]
54. Effect of particle size on the dissolution behaviors of poorly water-soluble drugs.
Chu KR; Lee E; Jeong SH; Park ES
Arch Pharm Res; 2012 Jul; 35(7):1187-95. PubMed ID: 22864741
[TBL] [Abstract][Full Text] [Related]
55. Miniaturized INtrinsic DISsolution Screening (MINDISS) assay for preformulation.
Alsenz J; Haenel E; Anedda A; Du Castel P; Cirelli G
Eur J Pharm Sci; 2016 May; 87():3-13. PubMed ID: 26360839
[TBL] [Abstract][Full Text] [Related]
56. In-line derivative spectroscopy as a promising application to a small-scale in vitro transfer model in biorelevant supersaturation and precipitation testing.
Jede C; Wagner C; Kubas H; Weber C; Weitschies W
J Pharm Pharmacol; 2018 Oct; 70(10):1315-1323. PubMed ID: 30062721
[TBL] [Abstract][Full Text] [Related]
57. Development and characterization of self emulsifying drug delivery system of a poorly water soluble drug using natural oil.
Sharma S; Bajaj H; Bhardwaj P; Sharma AD; Singh R
Acta Pol Pharm; 2012; 69(4):713-7. PubMed ID: 22876615
[TBL] [Abstract][Full Text] [Related]
58. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging.
Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A
Int J Pharm; 2015; 486(1-2):242-51. PubMed ID: 25835268
[TBL] [Abstract][Full Text] [Related]
59. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates.
Preis M; Grother L; Axe P; Breitkreutz J
Int J Pharm; 2015 Aug; 491(1-2):8-16. PubMed ID: 26051543
[TBL] [Abstract][Full Text] [Related]
60. The effect of the drying temperature on the properties of wet-extruded calcium stearate pellets: pellet microstructure, drug distribution, solid state and drug dissolution.
Schrank S; Kann B; Saurugger E; Hainschitz M; Windbergs M; Glasser BJ; Khinast J; Roblegg E
Int J Pharm; 2015 Jan; 478(2):779-87. PubMed ID: 25526671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
